ORTHOWORLD estimates Integra LifeSciences’ 1Q17 orthopaedic revenue at US $31.2MM, +19.6% from 1Q16.
| 1Q17 | 1Q1 6 | $ Change | % Change |
| Joint Recon Extremities | $6.1 | $5.1 | $1.0 | 19.0% |
| Trauma | $25.1 | $21.0 | $4.1 | 19.7% |
| Total | $31.2 | $26.1 | $5.1 | 19.6% |
Performance highlights:
- Sales of shoulder and ankle arthroplasty increased by double-digits, with especially strong demand for shoulder products in U.S.
- Launched Titan Press-Fit Reverse Shoulder at AAOS; had no press-fit version prior to this
- Commenced full launch of Cadence Total Ankle (has been used in >200 procedures in 7 countries since initial launch)
- Claims that Cadence + Salto position the company with the most competitive total ankle portfolio
- Launched a new external fixation system for ankle
Sources: Integra LifeSciences Corp.; ORTHOWORLD estimates
ORTHOWORLD estimates Integra LifeSciences’ 1Q17 orthopaedic revenue at US $31.2MM, +19.6% from 1Q16.
Q17
Q1 6
$ Change
% Change
Joint Recon Extremities
$6.1
$5.1
$1.0
19.0%
...
ORTHOWORLD estimates Integra LifeSciences’ 1Q17 orthopaedic revenue at US $31.2MM, +19.6% from 1Q16.
| 1Q17 | 1Q1 6 | $ Change | % Change |
| Joint Recon Extremities | $6.1 | $5.1 | $1.0 | 19.0% |
| Trauma | $25.1 | $21.0 | $4.1 | 19.7% |
| Total | $31.2 | $26.1 | $5.1 | 19.6% |
Performance highlights:
- Sales of shoulder and ankle arthroplasty increased by double-digits, with especially strong demand for shoulder products in U.S.
- Launched Titan Press-Fit Reverse Shoulder at AAOS; had no press-fit version prior to this
- Commenced full launch of Cadence Total Ankle (has been used in >200 procedures in 7 countries since initial launch)
- Claims that Cadence + Salto position the company with the most competitive total ankle portfolio
- Launched a new external fixation system for ankle
Sources: Integra LifeSciences Corp.; ORTHOWORLD estimates
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
